Trileptal Off-Label Promotion Subject Of Philadelphia U.S. Attorney Subpoena
This article was originally published in The Pink Sheet Daily
Executive Summary
Anti-epileptic understood to be subject of civil and criminal investigation into Novartis’ marketing practices. Trileptal subpoena is pursuant to HIPAA privacy provisions of 2003, company says.